Epidemiology and risk factors of peptic ulcer;Epidemiologie und risikofaktoren der gastroduodenalen ulcuskrankheit

Chirurg

Volumn 67, Issue 1, 1996, Pages 7-13

  Kreiss, Christianna ^a   Blum, A L ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Helicobacter pylori; Nonsteroidal anti inflammatory drugs; Peptic ulcer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

CROSS-SECTIONAL STUDY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; PEPTIC ULCER; PEPTIC ULCER BLEEDING; REVIEW; RISK FACTOR; SWITZERLAND;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-SECTIONAL STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; RISK FACTORS; SWITZERLAND;

EID: 0029681830     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Berstad K, Sjodahl R, Berstad A (1994) Phospholipase A2 activity in gastric juice from patients with active and H. pylori-eradicated healed duodenal ulcer. Aliment Pharmacol Ther 8: 175
2. Blaser MJ (1994) Helicobacter pylori phenotypes associated with peptic ulceration. Scand J Gastroenterol 29 [Suppl 205]: 1
3. Blecker U, Lanciers S, Mehta DI, Vandenplas Y (1994) Familial clustering of Helicobacter pylori infection. Clin Pediat 33: 307
4. Cohen S, Tyrrell DAJ, Smith AP (1991) Psychological stress and susceptibility to the common cold. N Engl J Med 325: 606
5. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330: 377
6. Crabtree JE, El-Omar E, Bugnoli M, Covacci A, et al (1994) Serum cagA IgG antibodies in Helicobacter pylori positive healthy volunteers and patients with dyspeptic disease. Gut 35 [Suppl 2]: S35
7. Crabtree JE, Farmery SM, Lindley IJD, Figura N, et al (1994) CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 47: 945
8. Cryer B, Feldman M (1992) Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage. Arch Intern Med 152: 1145
9. Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309: 901
10. El-Omar E, Penman I, Dorrian CA, Ardill JES, McColl KEL (1993) Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 34: 1060
11. Fischer L, Rørbæk Madsen M, Thomson H, Høst V, Wara P (1994) Peptic ulcer hemorrhage: Factors predisposing to recurrence. Scand J Gastroenterol 29: 414
12. Gasbarrini G, Pretolani S, Bonvincini F, Gatto MRA, et al (1995) A population based study of Helicobacter pylori infection in a European country: The San Marino study. Relations with gastrointestinal diseases. Gut 36: 838
13. Goggin PM, Collins DA, Jazrawi RP, Jackson PA, et al (1993) Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 34: 1677
14. Graham DY, Malaty HM, Evans DG, Evans DJ, et al (1991) Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology 100: 1495
15. Grant HW, Palmer KR, Riermesma RR, Oliver MF (1990) Duodenal ulcer is associated with low dietary linoleic acid intake. Gut 31: 997
16. Griffin MR, Piper JM, Daugherty JR, Snowden M, et al (1991) Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114: 257
17. Helmert U, Shea S (1994) Social inequalities and health status in Western Germany. Public Health 108: 341
18. Hochain P, Berkelmans I, Czernichow P, Guédon C, et al (1993) Risk factors for upper gastrointestinal bleeding related to use of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs). A case control study. Gastroenterology 104: A101
19. Hosking SW, Ling TKW, Chung SCS, Yung MY, et al (1994) Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomised controlled trial. Lancet 343: 508
20. Hsu PI, Lin XZ, Chan SH, Lin CY, et al (1994) Bleeding peptic ulcer-risk factors for rebleeding and sequential changes in endoscopic findings. Gut 35: 746
21. Jablonowski H, Hengels KJ, Kraemer N, Geis G, et al (1994) Effects of Helicobacter pylori on histamine and carbachol stimulated acid secretion by human parietal cells. Gut 35: 755
22. Jaramillo JL, Gálvez C, Carmona C, Montero JL, Miño G (1994) Prediction of further hemorrhage in bleeding peptic ulcer. Am J Gastroenterol 89: 2135
23. Jess P (1994) Personality pattern in peptic ulcer disease: A cohort study. J Intern Med 236: 271
24. Johnson R, Førde OH, Straume B, Burhol PG (1994) Aetiology of peptic ulcer: A prospective population study in Norway. J Epidemiol Commun Health 48: 156
25. Kato T, Nomura AMY, Stemmermann GN, Chyou PH (1992) A prospective study of gastric and duodenal ulcer and its relation to smoking, alcohol, and diet. Am J Epidemiol 135: 521
26. Katschinski BD, Logan RFA, Edmond M, Langman MJS (1990) Duodenal ulcer and refined carbohydrate intake: A case-control study assessing dietary fibre and refined sugar intake. Gut 31: 993
27. Katschinski BD, Zachewicz H, Goebell H (1992) Nonsteroidal antiinflammatory drugs and mortality from peptic ulceration in West Germany: 1952-1989. Dig Dis Sci 37: 385
28. Kawai K, Shirakawa K, Misaki F, Hayashi K, Watanabe Y (1989) Natural history and epidemiologic studies of peptic ulcer disease in Japan. Gastroenterology 96: 581
29. Khulusi S, Mendall MA, Badve S, Patel P, et al (1995) Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut 36: 193
30. Khulusi S, Mendall MA, Patel P, Levy J, Northfield TC (1994) Is there a quantifiable difference in H. pylori infection density between DU and non-DU patients? Gastroenterology 106: A106
31. Kim JG, Graham DY, The Misoprostol Study Group (1993) Helicobacter pylori infection and developement of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 89: 203
32. Kreiss C, Blum AL, Malfertheiner P (1996) Peptic ulcer pathogenesis. Curr Opin Gastroent 11 (Suppl 1) (im Druck)
33. Kurata JH, Nogawa AN, Abbey DE, Petersen F (1992) A prospective study of risk for peptic ulcer disease in seven-day adventists. Gastroenterology 102: 902
34. Labenz J, Börsch G (1994) Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 89: 1785
35. Labenz J, Börsch G (1994) Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 55: 19
36. Labigne A, Lamouliatte H, Birac C, Sedallian C, Mégraud F (1994) Distribution of the cagA gene among Helicobacter pylori strains associated with peptic ulcer. Am J Gastroenterol 89: 1326
37. Lanas A, Chandra S, Hirschowitz BI (1992) Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 103: 862
38. Langman MJS, Weil J, Wainwright P, Lawson DH, et al (1994) Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 343: 1075
39. Lanza FL (1993) Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 88: 1318
40. Lanza FL, Royer GL (1993) NSAID-induced gastric ulceration is dose related by weight: An endoscopic study with flurbiprofen. Am J Gastroenterol 88: 683
41. Laszewicz W, Gabryelewicz A, Sipponen P, Siurala M (1994) Helicobacter pylori infestation in gastric nicer disease: Followup of patients who did not receive antimicrobial treatment. Eur J Gastroenterol Hepatol 6: 733
42. La Vecchia C, Lucchini F, Negri E, Reggi V, Levi F (1993) The impact of therapeutic improvements in reducing peptic ulcer mortality in Europe. Int J Epidemiol 22: 96
43. Lee M, Cryer B, Feldman M (1994) Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. Ann Intern Med 120: 184
44. Leivonen M, Kivilaakso E (1991) Peptic ulcer bleeding today: risk factors and characteristics of the disease. Scand J Gastroenterol 26: 1013
45. Lichtenberger LM, Romero JJ, Ulloa C (1995) NSAIDs complexed to phosphatidylcholine have reduced GI toxicity and enhanced bioavailability. Gastroenterology 108: A149
46. Loperfido S, Monica F, Maifreni L, Paccagnella A (1994) Bleeding peptic ulcer occurring in hospitalized patients: Analysis of predictive and risk factors and comparison with out-of-hospital onset of hemorrhage. Dig Dis Sci 39: 698
47. MacDonald TM, Morant SV, Robinson GC, Shield MJ, et al (1995) The risk of serious upper GI complications is constant with continuous NSAID therapy: Results of a record linkage study in 52382 exposed patients. Gastroenterology 108: A156
48. Malaty HM, Engstrand M, Pedersen NL, Graham DY (1994) Helicobacter pylori infection: Genetic and environmental influences. Ann Intern Med 120: 982
49. McMahon AD, White G, Murray FE, McGilchrist MM, et al (1995) New exposure to NSAIDs and hospitalisation for upper gastro-intestinal events and haemorrhage: A record-linkage study in the population of Tayside, Scotland. Gastroenterology 108: A164
50. Miehlke S, Bayerdörffer E, Lehn N, Mannes GA, et al (1995) Risk prediction of duodenal ulcer relapse. Gastroenterology 108: A167
51. Müller X, Rothenbuehler JM, Amery A, Harder F (1994) Factors predisposing to further hemorrhage and mortality after peptic ulcer bleeding J Am Coll Surg 179: 457
52. Neri M, Susi D, Bovani I, Laterza F, et al (1994) Bacterial mucosal infiltration in Helicobacter pylori-associated gastritis: Histological and clinical consequences. Am J Gastroenterol 89: 1801
53. NIH Consensus Conference (1994) Helicobacter pylori in peptic ulcer disease. JAMA 272: 65
54. Nomura A, Stemmermann GN, Po-Huang C, Perez-Perez GI, Blaser MJ (1994) Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 120: 977
55. Ohmann C, Thon K, Hengels KJ, Imhof M, Düsük Study Group (1992) Incidence and pattern of peptic ulcer bleed-ing in a defined geographical area. Scand J Gastroenterol 27: 571
56. Persson E, Hanson BS, Rastam AS (1994) Alcohol habits among teenagers in Sweden: Factors of importance. J Stud Alcohol 55: 719
57. Peura DA, Graham DY (1994) Helicobacter pylori: Consensus reached: Peptic ulcer is on the way to becoming an historic disease. Am J Gastroenterol 89: 1137
58. Piper JM, Ray WA, Daugherty JM, Griffin MR (1991) Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 114: 735
59. Rautelin H, Blomberg B, Fredlund H, Järnerot G, Danielson D (1993) Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 34: 599
60. Rautelin H, Blomberg B, Järnerot G, Danielsson D (1994) Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: Ulcerogenic markers. Scand J Gastroenterol 29: 128
61. Rosenstock SJ, Jørgensen T (1995) Prevalence and incidence of peptic ulcer disease in a Danish county - a prospective cohort study. Gut 36: 819
62. Savage RL, Moller PW, Ballantyne CL, Wells JE (1993) Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthr Rheumat 36: 84
63. Scheiman JM, Behler EM, Crause I, Gorlach E (1995) Mucosal protection from NSATD-induced injury by low dose octreotide in humans. Gastroenterology 108: A212
64. Schöön TM, Mellström D, Odén A, Ytterberg BG (1991) Peptic ulcer disease in older age groups in Gothenburg in 1985: The association with smoking. Age Ageing 20: 371
65. Schubert TT, Bologna SD, Nensey Y, Schubert AB, et al (1993) Ulcer risk factors: Interactions between Helicobacter pylori infection, nonsteroidal use, and age. Am J Med 94: 413
66. Shorr RI, Ray WA, Daugherty JR, Griffin MR (1993) Concurrent use of nonsteroidal anti-inflammatory drugs and oral anti-coagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 153: 1665
67. Shorrock CJ, Langman MJS, Warlow C (1992) Risks of upper GI bleeding during TIA prophylaxis with aspirin. Gastroenterology 102: A165
68. Shorrock CJ, Rees WD (1992) Mucosal adaptation to indomethacin induced gastric damage in man - studies on morphology, blood flow, and prostaglandin E2 metabolism. Gut 33: 164
69. Sitas F, Forman D, Yarnell JWG, Burr ML, et al (1991) Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 32: 25
70. Sonnenberg A (1988) Concordant occurrence of gastric and hypertensive diseases. Gastroenterology 95: 42
71. Sonnenberg A (1993) The US temporal and geographic variations of diseases related to Helicobacter pylori. Am J Public Health 83: 1006
72. Sonnenberg A, Everhart JE (1995) Current prevalence rates and risk factors of peptic ulcer in the United States. Gastroenterology 108: A223
73. Stalnikowicz R, Rachmilewitz D (1993) NSAID-induced gastroduodenal damage: Is prevention needed? A review and metaanalysis. J Clin Gastroenterol 17: 238
74. Sue SO, Murdock RH, Sullivan JA, Kleoudis CS (1995) Ranitidine in the prevention of NSAID-associated ulcers in patients with arthritis. Gastroenterology 108: A228
75. Sung JJY, Chung S, Ling TKW, Yimg MY, et al (1995) Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engi J Med 332: 139
76. Taha AS, Dahill S, Nakshabendi I, Lee FD, et al (1993) Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 34: 1162
77. Taha AS, Dahill S, Sturrock RD, Lee FD, et al (1994) Predicting NSAID related ulcers - assessment of clinical and pathological risk factors and importance of differences in NSAID. Gut 35: 891
78. Taha AS, Sturrock RD, Russell RI (1995) Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori. Gut 36: 334
79. Telford JL, Ghiara P, Dell, Orco M, Comanducci M, et al (1994) Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 179: 1653
80. Thompson L, Cockayne A, Spiller RC (1994) Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: A possible explanation of the effect of diet on peptic ulceration. Gut 35: 1557
81. Tovey FI (1994) Diet and duodenal ulcer. J Gastroenterol Hepatol 9: 177
82. Tsugane S, Tei Y, Takahashi T, Watanabe S, Sugano K (1994) Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res 85: 474
83. Tummuru MK, Sharma SA, Blaser MJ (1995) Helicobacter pylori cagC, a homolog of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Gastroenterology 108: A246
84. Wallace JL, Reuter B, Cicala C, McKnight W (1994) Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107: 173
85. Weil J, Colin-Jones D, Langman MJS, Lawson DH, et al (1995) Prophylactic aspirin and peptic ulcer bleeding. Gastroenterology 108: A256
86. Wilhelmsen I, Bakke A, Tangen Haug T, Endresen IM, Berstad A (1994) Psychological adjustment to illness scale (PAIS-SR) in a Norwegian material of patients with functional dyspepsia, duodenal ulcer, and urinary bladder dysfunction. Scand J Gastroenterol 29: 611
87. Wolfe F (1991) The epidemiology NSAID associated gastrointestinal disease. Eur J Rheumatol Inflamm 3: 12
88. Younossi ZM, Strum WB, Cloutier D, Teirstein PS, Schatz RA (1995) Upper GI bleeding in postcoronary stem patients following aspirin and anticoagulant treatment. Gastroenterology 108: A265
89. Zeidler H (1992) Epidemiology and economics of NSAID-iduced gastropathy. Scand J Rheumatol [Suppl 92] 3